Common side effects and effective coping strategies of sotorasib (AMG 510)

Sotorasib (formerly known as AMG 510) is an oral small molecule targeted drug targeting KRAS G12C mutation-positive non-small cell lung cancer (NSCLC). KRAS mutation is one of the common driver gene mutations in non-small cell lung cancer. Traditional chemotherapy or immunotherapy has limited efficacy in patients with this type of mutation. Sotorasiib specifically inhibits the activity of KRAS G12C protein and blocks downstream signaling pathways, thereby inhibiting tumor cell proliferation and promoting apoptosis, providing a new targeted treatment option for patients with advanced stages or who have failed previous treatments.

Although sotoraxib has good targeting properties, a variety of side effects may still occur in clinical application. The most common adverse reactions include diarrhoea, nausea, vomiting, abnormal liver function (ALT/ASTelevated), fatigue and rash. Some patients may also experience decreased appetite, constipation, hypokalemia, or mild hypertension. Abnormal liver function is one of the most concerning side effects of sotoraxib, which is usually manifested as an increase in serum aminotransferases. In severe cases, it may lead to jaundice or liver damage, so liver function indicators need to be monitored regularly.

For these side effects, effective coping strategies are critical. First of all, for abnormal liver function, patients should conduct a baseline liver function assessment before taking the drug, and conduct regular reexaminations as directed by the doctor during treatment. If there is a mild increase in ALT/AST, you can continue to observe and take symptomatic treatment; if there is a moderate or severe increase, the medication should be suspended or the dose should be adjusted, and hepatoprotective or supportive treatment should be used under the guidance of a doctor. Secondly, digestive tract symptoms (such as diarrhea, nausea, vomiting) can be alleviated through small frequent meals, low-fat diet, maintaining water replenishment, etc. At the same time, antidiarrheal drugs or anti-vomiting drugs can be used under the guidance of a doctor.

In addition, patients should pay close attention to skin and systemic reactions while taking the drug. If rash, itching or allergic symptoms occur, they should report to their doctor in time and use anti-allergic drugs or adjust the dosage if necessary. Fatigue or loss of appetite can be improved through regular work and rest, moderate exercise and nutritional support. It needs to be emphasized that patients should not stop taking medication or increase or decrease the dosage on their own, but should make adjustments under the guidance of a doctor to ensure efficacy while reducing the risk of side effects.

In terms of daily management, patients and their families should establish good medication and symptom recording habits. Record daily drug dosage, medication time, and discomfort reactions. This will help doctors promptly determine the type and severity of side effects and formulate personalized management plans. At the same time, patients are advised to maintain a balanced diet, regular work and rest, moderate exercise, and avoid using drugs or health products that may increase the burden on the liver to reduce the risk of side effects. For patients with underlying liver disease or multiple medications, comprehensive evaluation and monitoring should be conducted under the guidance of a doctor.

In general, sotoracib has significant efficacy in patients with KRAS G12C -positive non-small cell lung cancer, but there is still a certain risk of side effects. Through early monitoring, individualized dose adjustment, symptomatic treatment and daily life management, most side effects can be effectively controlled. Patients who insist on standardized treatment and maintain close communication with their doctors can not only maximize the efficacy of the drug, but also significantly improve their quality of life and ensure the safe and smooth progress of targeted therapy.

Reference link:https://www.drugs.com